![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/22 | (2006.01) |
A61K 9/0048 | (2013.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/12 | (2013.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 31/194 | (2013.01) | ||
A61K 47/02 | (2006.01) | ||
A61K 47/02 | (2013.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 38/2292 | (2013.01) | ||
A61K 31/194 | (2006.01) | ||
A61K 9/08 | (2013.01) | ||
A61P 27/02 | (2006.01) | ||
A61P 27/02 | (2018.01) |
(11) | Patento numeris | 3338792 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16837270.4 |
Europos patento paraiškos padavimo data | 2016-08-12 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-06-27 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/KR2016/008924 |
Data | 2016-08-12 |
(87) | Numeris | WO 2017/030328 |
Data | 2017-02-23 |
(30) | Numeris | Data | Šalis |
20150116089 | 2015-08-18 | KR |
(72) |
KANG, Sin Wook , KR
KIM, Kyoungsun , KR
SUNG, Ji Hye , KR
|
(73) |
HLB Therapeutics Co., Ltd. ,
22F, 248 Jeongjail-ro
Bundang-gu, Seongnam-si, Gyeonggi-do 13554,
KR
|
(54) | CORNEAL DAMAGE PREVENTION/TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AND CITRIC ACID AS ACTIVE INGREDIENTS |
CORNEAL DAMAGE PREVENTION/TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AND CITRIC ACID AS ACTIVE INGREDIENTS |